ATE140967T1 - Neue polypeptide, deren kodierende dns - Google Patents

Neue polypeptide, deren kodierende dns

Info

Publication number
ATE140967T1
ATE140967T1 AT93301571T AT93301571T ATE140967T1 AT E140967 T1 ATE140967 T1 AT E140967T1 AT 93301571 T AT93301571 T AT 93301571T AT 93301571 T AT93301571 T AT 93301571T AT E140967 T1 ATE140967 T1 AT E140967T1
Authority
AT
Austria
Prior art keywords
polypeptide
coding dna
new polypeptides
treatment
aplasia
Prior art date
Application number
AT93301571T
Other languages
English (en)
Inventor
Takayuki C O Manase Res Naitoh
Co Ltd - - Saku Pharmaceutical
Mikio C O Minase Resea Konishi
Tsumoru C O Minase Re Miyamoto
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE140967T1 publication Critical patent/ATE140967T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT93301571T 1992-03-03 1993-03-02 Neue polypeptide, deren kodierende dns ATE140967T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8155792 1992-03-03
JP12955892 1992-04-22

Publications (1)

Publication Number Publication Date
ATE140967T1 true ATE140967T1 (de) 1996-08-15

Family

ID=26422579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93301571T ATE140967T1 (de) 1992-03-03 1993-03-02 Neue polypeptide, deren kodierende dns

Country Status (9)

Country Link
EP (1) EP0559428B1 (de)
JP (1) JPH0656895A (de)
AT (1) ATE140967T1 (de)
CA (1) CA2090639A1 (de)
DE (1) DE69303840T2 (de)
DK (1) DK0559428T3 (de)
ES (1) ES2092758T3 (de)
GR (1) GR3021294T3 (de)
TW (1) TW288019B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006423A1 (en) * 1997-07-30 1999-02-11 Human Genome Sciences, Inc. 83 human secreted proteins
US7022507B1 (en) 1999-03-16 2006-04-04 Incyte Corporation Isolated polynucleotide encoding a human PSST subunit of the NADH:ubiquinone oxidoreductase complex

Also Published As

Publication number Publication date
EP0559428A3 (en) 1993-12-01
ES2092758T3 (es) 1996-12-01
DE69303840T2 (de) 1997-01-16
JPH0656895A (ja) 1994-03-01
TW288019B (de) 1996-10-11
GR3021294T3 (en) 1997-01-31
EP0559428A2 (de) 1993-09-08
DK0559428T3 (da) 1996-08-26
DE69303840D1 (de) 1996-09-05
CA2090639A1 (en) 1993-09-04
EP0559428B1 (de) 1996-07-31

Similar Documents

Publication Publication Date Title
PL340755A1 (en) Polypeptide-10 similar to mammal cytokin
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
PT80301A (de) Neue polypeptide mit blutgerinnungshemmender wirkung verfahren zu deren herstellung bzw. gewinnung deren verwendung und diese enthaltende mittel
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
ATE109793T1 (de) Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.
KR900011900A (ko) 이.콜라이내에서 펩타이드를 분비시키기 위한 시그날 펩타이드 및 이를 암호화하는 유전자
DE69032043D1 (de) Proteinkomplexe mit faktor viii:c-aktivität und deren herstellung
EG18472A (en) Anti inflammatory furanones
ATE424410T1 (de) Interleukin-19.
GB8821785D0 (en) Peptide compounds
DE69303840D1 (de) Neue Polypeptide, deren kodierende DNS
DE69617321D1 (de) Anlasser mit Kontaktor versehen mit verbesserten Mitteln zur Endung in Rohelage, und Kontaktor mit solchen Mitteln versehen
DE69636320D1 (de) Helicobacter Polypeptide, deren Herstellung und Verwendung
GB9121965D0 (en) Method for expressing polypeptides in e.coli and recombinant molecules useful therefor
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
ATE310083T1 (de) Deprenyl induziertes protein
小泉武 Relationship between amino acid transport and protein synthesis in rat isolated pancreatic acini under stimulation with cholecystokinin.
WO1998057985A3 (en) Human rip-interacting factor (rif)
ATA259687A (de) Peptide mit einfluss auf die diurese und natriurese, diese enthaltende mittel und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee